BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 11188957)

  • 1. [Streptococcus pyogenes: penicillin and erythromycin susceptibility in the cities of Neuquen and Cipolletti].
    Soriano SV; Brasili S; Saiz M; Carranza C; Vidal P; Calderón J; Lopardo HA
    Medicina (B Aires); 2000; 60(4):487-90. PubMed ID: 11188957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to erythromycin and rising penicillin MIC in Streptococcus pyogenes in India.
    Capoor MR; Nair D; Deb M; Batra K; Aggarwal P
    Jpn J Infect Dis; 2006 Oct; 59(5):334-6. PubMed ID: 17060703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Phenotypic characterization of erythromycin resistance in strains of the genus Streptococcus isolated from clinical specimens].
    Limia A; Jiménez ML; Delgado T; Sánchez I; López S; López-Brea M
    Rev Esp Quimioter; 1998 Sep; 11(3):216-20. PubMed ID: 9795307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythromycin-resistant Streptococcus pyogenes in Argentina.
    Lopardo HA; Hernandez C; Vidal P; Vazquez M; Rosaenz L; Rubinstein G; Smayevsky J; Tokumoto M; Fernandez Lausi A; Daher O; Kaufman S; Soriano SV; Brasili S; Bottiglieri M; Carranza MC
    Medicina (B Aires); 2004; 64(2):143-5. PubMed ID: 15628302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Macrolide antibiotic resistance rates and phenotypes of group A beta hemolytic streptococci isolated between the years 1999-2000 and 2001-2002].
    Senses Z; Baysallar M; Gür D; Doğanci L
    Mikrobiyol Bul; 2003 Oct; 37(4):225-34. PubMed ID: 14748258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the degree of susceptibility of Streptococcus pyogenes erythromycin-resistant strains to rokitamycin (a 16-membered macrolide) using the Epsilometer test.
    Crotti D; Rossetti R; Braga PC
    Drugs Exp Clin Res; 2004; 30(1):17-26. PubMed ID: 15134387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Susceptibility of Streptococcus pyogenes to macrolides and quinolones in Guadalajara, Spain].
    Rodríguez-Zurita ME; Solís del Baño S; Robres Guillén P; González Praetorius A; Gimeno Fernández C; Pérez Pomata MT; Bisquert Santiago J
    Rev Esp Quimioter; 2003 Mar; 16(1):61-4. PubMed ID: 12750759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Argentinian collaborative study on prevalence of erythromycin and penicillin susceptibility in Streptococcus pyogenes. The Argentinian Streptococcus Study Group.
    Lopardo HA; Venuta ME; Vidal P; Rosaenz L; Corthey C; Farinati A; Couto E; Sarachian B; Sparo M; Kaufman S; De Mier CA; Gubbay L; Scilingo V; Villaverde P
    Diagn Microbiol Infect Dis; 1997 Sep; 29(1):29-32. PubMed ID: 9350412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Differentiation of resistance phenotypes among erythromycin-resistant streptococci].
    Bejuk D
    Acta Med Croatica; 2004; 58(4):301-6. PubMed ID: 15700686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrolide resistance among middle ear isolates of Streptococcus pneumoniae observed at eight United States pediatric centers: prevalence of M and MLSB phenotypes.
    Mason EO; Wald ER; Bradley JS; Barson WJ; Kaplan SL;
    Pediatr Infect Dis J; 2003 Jul; 22(7):623-7. PubMed ID: 12867838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003.
    Richter SS; Heilmann KP; Beekmann SE; Miller NJ; Miller AL; Rice CL; Doern CD; Reid SD; Doern GV
    Clin Infect Dis; 2005 Sep; 41(5):599-608. PubMed ID: 16080080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Emergence of macrolide resistant Streptococcus pyogenes strains in pediatric patients in France].
    Mariani-Kurkdjian P; Doit C; Deforche D; Brahimi N; Francois M; Van den Abbeele T; Bingen E
    Pathol Biol (Paris); 2004 Oct; 52(8):489-92. PubMed ID: 15465270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from blood cultures in Korea.
    Uh Y; Shin DH; Jang IH; Hwang GY; Lee MK; Yoon KJ; Kim HY
    J Antimicrob Chemother; 2004 Jun; 53(6):1095-7. PubMed ID: 15117924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Macrolide resistance phenotypes and genotypes in group G streptococci].
    Açikgöz ZC; Göçer S; Almayanlar E
    Mikrobiyol Bul; 2003; 37(2-3):117-24. PubMed ID: 14593892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antibiotic sensitivity of Streptococcus pyogenes in pediatrics].
    Gené A; González-Cuevas A; Juncosa T; Luaces C; Latorre C
    Enferm Infecc Microbiol Clin; 1998; 16(6):272-4. PubMed ID: 9763744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia.
    Gosbell IB; Fernandes LA; Fernandes CJ
    Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Susceptibility of Streptococcus pyogenes isolates from pharyngeal exudates in Cordoba (Spain)].
    Gordillo RM; Lacasa MJ; Ibarra A; Rodríguez F; Casal M
    Rev Esp Quimioter; 2003 Mar; 16(1):58-60. PubMed ID: 12750758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral antimicrobial susceptibilities of Streptococcus pyogenes recently isolated in five countries.
    Bandak SI; Turnak MR; Allen BS; Bolzon LD; Preston DA
    Int J Clin Pract; 2000 Nov; 54(9):585-8. PubMed ID: 11220986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and mechanisms of macrolide resistance in Streptococcus pyogenes in Ankara, Turkey.
    Colakoglu S; Alacam R; Hascelik G
    Scand J Infect Dis; 2006; 38(6-7):456-9. PubMed ID: 16798693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Emergence of resistance to macrolides in Streptococcus pyogenes].
    Vinagre C; Cifuentes M; Valdivieso F; Ojeda A; Prado V
    Rev Med Chil; 1999 Dec; 127(12):1447-52. PubMed ID: 10835751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.